LOGIN
AAOS 2016: TXA vs. epsilon-aminocaproic acid provide comparable outcomes after TKA
March 2016
AAOS 2016: TXA vs. epsilon-aminocaproic acid provide comparable outcomes after TKA
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Tranexamic Acid and Epsilon-Aminocaproic Acid to Reduce Blood Loss Following Total Knee Arthroplasty
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
140 patients scheduled for total knee arthroplasty (TKA) were randomized to be administered either tranexamic acid or epsilon-aminocaproic acid. The purpose of this study was to compare the antifibrolytic effects of the two drugs after total knee arthroplasty. Findings indicated no significant differences in transfusion rates, drop in haemoglobin (Hb) levels, serum creatinine change, and postopera...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.